ArticleRSC advances2025
MD-enhanced DFT investigation of β-cyclodextrin as drug delivery system for Ampyra drug.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cyclodextrins (CDs) have emerged as a promising strategy for the targeted drug delivery process. Herein, the potential of β-cyclodextrin (β-CD) as a drug delivery system for the Ampyra (AMP) drug was extensively investigated. By means of the molecular dynamics (MD) simulation technique, the inclusion process of AMP with β-CD was first examined and consequently subjected to clustering analysis. Upon the obtained five configurations (A↔E) of AMP⋯β-CD complex, extensive density functional theory (DFT) calculations were executed. The favorability of the quested encapsulation process was affirmed by negative adsorption and interaction energies of the selected configurations A↔E affirmed the occurrence of the quested encapsulation process. In particular, configuration A is more energetically preferred compared to other analogs. The insights from SAPT analysis verified the dominant role of electrostatic and dispersion forces in the interactions within the studied configurations A↔E. From QTAIM and NCI analyses, the occurrence and nature of intermolecular interactions within the studied configurations A↔E were illustrated. As per the electronic analysis, the effect of the AMP encapsulation process on the electronic features of β-CD was emphasized. The enhancing impact of the aqueous medium on the studied configurations A↔E was verified by negative adsorption and solvation energies. Moreover, the calculated recovery time values pinpointed the separation potential of AMP from β-CD at the target cell. Overall, the obtained outcomes provided insights into the potential application of β-CD as a drug delivery system, particularly for AMP drug.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.